Fertility Treatments Global Market Report 2024

The fertility treatments market size has grown strongly in recent years. It will grow from $16.54 billion in 2023 to $17.97 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed during the historical period can be attributed to various factors, including the increasing rates of infertility, advancements in the field of reproductive medicine, improved healthcare coverage that facilitates access to fertility treatments, and efforts to raise awareness and reduce the social stigma associated with infertility. These factors have contributed to the expansion of the fertility treatment industry, making it more accessible to individuals seeking assistance with their reproductive health.

The fertility treatments market size is expected to see strong growth in the next few years. It will grow to $25.02 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%.

The anticipated growth in the forecast period can be attributed to various factors, including delayed childbearing trends, the expansion of reproductive services and facilities, ongoing technological advancements in fertility treatments, and increased accessibility to fertility services. These factors are expected to drive the growth of the fertility treatment industry, allowing more individuals and couples to seek assistance with their reproductive challenges. Prominent trends in the forecast period include advancements in in vitro fertilization (IVF) techniques, the adoption of single embryo transfer (SET) methods to improve success rates, the integration of telehealth and virtual consultations to enhance patient care, and the growing importance of fertility preservation services for cancer patients and individuals looking to preserve their fertility for future family planning. These trends reflect the evolving landscape of fertility treatment and its continued development to address the diverse needs of patients.

The primary product categories associated with fertility treatment include reagents and equipment. Reagents are substances or compounds that are added to a system to induce a chemical reaction or to assess the occurrence of a reaction. Fertility treatments are typically carried out on both male and female patients and are offered in a variety of healthcare settings, including fertility clinics, hospitals, surgical centers, and clinical research institutes. These facilities provide a range of medical interventions to address infertility and improve the chances of conceiving offspring.

The fertility treatment market research report is one of a series of new reports that provides fertility treatment market statistics, including fertility treatment industry global market size, regional shares, competitors with a fertility treatment market share, detailed fertility treatment market segments, market trends and opportunities, and any further data you may need to thrive in the fertility treatment industry. This fertility treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fertility treatments market is expected to see growth due to several factors, including the increasing median age of first-time motherhood and lifestyle changes, which have made conception more challenging. A significant global trend is the rise in the median age of first-time mothers due to factors such as delayed marriages, the use of contraceptive methods, and women prioritizing their careers over starting families. For instance, in the United States, the average age of first-time mothers increased from 25.6 in 2011 to 27.3 in 2021. This shift towards delayed motherhood is observed in other developed countries, with the typical first birth occurring at the age of 31 for new mothers. Consequently, an increasing number of women are opting for fertility treatments like in vitro fertilization (IVF), thus driving the fertility treatments market.

The decline in fertility rates is another key driver for the fertility treatments market. Declining fertility refers to a reduction in individuals' or couples' ability to conceive and have biological children, often due to factors such as age, medical conditions, lifestyle choices, or environmental influences. Fertility treatments, including intrauterine insemination (IUI) and IVF, address infertility issues by employing medical interventions to increase the chances of conception for those facing a decrease in fertility. In 2021, worldwide fertility rates decreased from an average of 5 births per woman in 1950 to 2.3 births per woman, according to the United Nations Population Fund. This reflects the growing control individuals, particularly women, have over their reproductive lives. The overall fertility rate is projected to further decline to 2.1 births per woman by 2050, thus boosting the demand for fertility treatments.

The high cost and relatively low success rate of in vitro fertilization (IVF) treatments pose limitations to the growth of the fertility treatments market. IVF is a fertilization process where an egg is fertilized with sperm outside the body. The cost of IVF treatment varies between countries, and many lack refund policies. Additionally, infertility treatments are typically not covered by insurance. For instance, in the United States, the average cost of an IVF cycle is $12,400, with the average cost of a cycle using fresh embryos at $8,158, and a median cost of $7,500. The success rates of IVF treatments range from 28% to 35%, and these rates decrease with the woman's age. For women under 35, the success rate is 32.2%, but it drops to 1.9% for women over 44. These cost and success rate factors present challenges to the growth of the fertility treatment market.

A notable trend in the fertility treatments market is the development of innovative techniques to treat infertility within the human body. One such example is INVOcell, an alternative to traditional IVF that uses the woman's body to support fertilization, eliminating the need for a laboratory incubator. INVOcell, developed by INVO Bioscience in Medford, Massachusetts, costs around $6,800, including medication. Although IVF typically generates more quality embryos, the birth rates achieved with INVOcell are similar to those of traditional IVF. Such innovations are reshaping the landscape of fertility treatments and addressing cost and success rate challenges.

Major companies operating in the fertility treatments market are also utilizing artificial intelligence (AI) technology to enhance IVF treatments. AI has the potential to revolutionize fertility care by providing personalized, data-driven insights for clinicians and patients. For example, in October 2022, Alife Health, a U.S.-based healthcare company, introduced new artificial intelligence software designed to improve IVF treatment outcomes, reduce costs, and optimize clinical decision-making at critical stages of the IVF process.

In August 2022, CCRM Fertility, an American fertility treatment company, acquired the Institute for Reproductive Medicine & Sciences (IRMS) to enhance its offerings and expand its presence across 11 major metropolitan areas with 34 locations in the United States and Canada. This strategic acquisition added proprietary reproductive medicine solutions to CCRM's portfolio, strengthening its position in the fertility treatment market.

Major companies operating in the fertility treatments market include Apollo Hospitals Enterprise Ltd., Care Fertility Group Limited, Genea Limited, Johns Hopkins Health System Corp., Medicover AB, Monash IVF Group, Progyny Inc., Vitrolife AB, Carolinas Fertility Institute PLLC, OvaScience Inc., Xytex Cryo International Ltd., Merck Group, Cook Group Incorporated, CooperSurgical Inc., Instituto Bernabeu, INVO Bioscience Inc., Cooper Companies Inc., Virtus Health Ltd., CryoChoice LLC, Millendo Therapeutics Inc., FUJIFILM Irvine Scientific Inc., LABOTECT GMBH, Fertility Focus Limited, Olympus Corporation, Irvine Scientific sales Company Inc., Ferring Pharmaceuticals Inc., Prelude Fertility Inc., Boston IVF, RMA Fertility Clinics, Shady Grove Fertility, CCRM Management Company LLC, IVIRMA Global, CARE Fertility

North America was the largest region in the fertility treatment market in 2023. Western Europe was the second largest region in the fertility treatment market. The regions covered in the fertility treatments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fertility treatments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The fertility treatment market includes revenues earned by entities by providing medicinal services, surgical services, and assisted services such as in vitro fertilization. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.